Bulletin
Investor Alert

UroGen Pharma Ltd.

NAS: URGN

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202929873/composite

$

19.31

Change

0.00 0.00%

Volume

Volume 1,784

Sep 25, 2020, 4:41 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202929873/composite

Previous close

$ 19.30

$ 19.31

Change

+0.01 +0.05%

Day low

Day high

$19.08

$19.83

Open
Open: 19.14

52 week low

52 week high

$13.12

$35.21

Open

Market cap

$425.28M

Average volume

161,875

P/E ratio

N/A

Rev. per Employee

$16,114

EPS

-6.15

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/urgn

MarketWatch News on URGN

  1. UroGen Pharma stock price target cut to $41 from $61 at Stifel Nicolaus

    8:07 a.m. Oct. 21, 2019

    - Tomi Kilgore

  2. UroGen Pharma stock price target cut to $61 from $63 at Stifel Nicolaus

    9:12 a.m. Aug. 13, 2019

    - Tomi Kilgore

  3. UroGen initiated at neutral at JPMorgan

    8:22 a.m. May 30, 2019

    - Ciara Linnane

  4. UroGen Pharma upgraded to outperform from market perform at Raymond James

    7:58 a.m. April 4, 2018

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/urgn

Other News on URGN

  1. UroGen Pharma trades high; expands executive leadership team

    11:23 a.m. Sept. 9, 2020

    - Seeking Alpha

  2. Oncology Stocks Area Trading Materially Lower The Last 2 Months

    8:00 a.m. Aug. 24, 2020

    - Seeking Alpha

  3. 10-Q: UROGEN PHARMA LTD.

    8:17 a.m. Aug. 10, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  4. 10-Q: UROGEN PHARMA LTD.

    7:07 a.m. May 7, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  5. UroGen Is A Compelling Value With Recent FDA Approval

    2:50 a.m. April 28, 2020

    - Seeking Alpha

  6. 7 Stocks to Buy for Their Double-Digit Growth Prospects

    11:05 a.m. April 27, 2020

    - InvestorPlace.com

  7. INO, BBBY among premarket gainers

    9:19 a.m. April 16, 2020

    - Seeking Alpha

  8. FDA OKs UroGen's mitomycin gel for rare urothelial cancer

    3:21 p.m. April 15, 2020

    - Seeking Alpha

  9. UroGen (URGN) Looks Good: Stock Adds 8.1% in Session

    8:53 a.m. April 6, 2020

    - Zacks.com

  10. UroGen's UGN-102 shows positive effect ih bladder cancer study

    8:34 a.m. April 3, 2020

    - Seeking Alpha

  11. Stocks To Watch: 0% To The Rescue?

    8:49 a.m. March 14, 2020

    - Seeking Alpha

  12. 10-K: UROGEN PHARMA LTD.

    8:52 a.m. March 2, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  13. Loading more headlines...
/news/pressrelease/company/us/urgn

Press Releases on URGN

  1. UroGen Pharma Announces September 2020 Conference Schedule

    8:00 a.m. Sept. 10, 2020

    - BusinessWire - BZX

  2. Non Muscle Invasive Bladder Cancer Pipeline Insight, 2020

    6:42 p.m. July 15, 2020

    - ABNewswire

  3. UroGen Pharma to Present at Jefferies Virtual Healthcare Conference

    8:00 a.m. June 1, 2020

    - BusinessWire - BZX

  4. Loading more headlines...

Rates »

Trending Tickers
  • /quotes/zigman/17636479/composite VUZI+15.60%
  • /quotes/zigman/237947/composite JCP-5.83%
  • /quotes/zigman/59392505/composite NUGT-2.93%
  • /quotes/zigman/59386294/composite JNUG-5.94%
  • /quotes/zigman/65801738/composite TLT+1.11%
X
Powered by StockTwits
Link to MarketWatch's Slice.